FDA OKs Aurobindo’s generic SensiparCinacalcet hydrochloride tablets had a market value of roughly $1.45 billion for the 12 months ended May 2019, according to IQVIA. Novadoz/MSN Labs’ generic Lyrica gets FDA clearancePregabalin is indicated for epilepsy, neuropathic pain, fibromyalgia, and restless leg syndrome. It also is used to treat epilepsy as adjunctive therapy for partial seizures. FDA approves Unichem’s generic Ultram Unichem Laboratories has received the FDA's nod for a generic treatment for severe pain. Hikma inks distribution deal with Civica Rx Hikma will manufacture and supply 14 medications for generics company Civica Rx. Unichem Labs gets FDA green light for generic Hygroton Unichem Labs' generic Hygroton is available in two dosage strengths. Teva launches generic EpiPen Jr. Teva's generic of EpiPen Jr., like it's previously launched generic of EpiPen, uses Antares Pharma's Vibrex auto-injection device. Dr. Reddy’s introduces generic Sabril The Sabril brand and generic had a market value of roughly $274 million for the most recent 12 months ended June 2019. Aurobindo gets FDA's OK for generic Salagen Pilocarpine hydrochloride tablets had a market value of $18 million for the 12 months ending June 2019, according to IQVIA. Sandoz to appeal court ruling on Enbrel biosimilar Sandoz expects to appeal a court ruling to the United States Court of Appeals for the Federal Circuit for Erelzi, its biosimilar of Amgen's Enbrel. Jeffrey Smith resigns from Perrigo board of directors Jeffrey Smith, managing member, CEO and chief investment officer of Starboard Value, who has been a director since 2017, has resigned from Perrigo's board of directors First Previous 180 181 182 183 184 Next Last
